Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P3IZ
|
|||
| Former ID |
DIB007231
|
|||
| Drug Name |
E-2040
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Terminated | [1] | |
| Company |
Eisai Co Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H23BN2O3
|
|||
| Canonical SMILES |
B1(OC(C(O1)(C)C)(C)C)C=CC2=CN=C(C=C2OCC)N
|
|||
| InChI |
1S/C15H23BN2O3/c1-6-19-12-9-13(17)18-10-11(12)7-8-16-20-14(2,3)15(4,5)21-16/h7-10H,6H2,1-5H3,(H2,17,18)/b8-7+
|
|||
| InChIKey |
LHNZICNYYCFWCS-BQYQJAHWSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009126) | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009126) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.